These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Biotransformation of cyclosporin G in comparison to cyclosporine. Mangold JB; Schran HF; Yatscoff RW; Weitzel WF; Leichtman AB Transplant Proc; 1994 Oct; 26(5):3013-6. PubMed ID: 7940950 [No Abstract] [Full Text] [Related]
7. Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients. Tredger JM; Naoumov NV; Steward CM; O'Grady JG; Grevel J; Niven AA; Kelman AW; Whiting B; Williams R Transplant Proc; 1988 Apr; 20(2 Suppl 2):512-5. PubMed ID: 3284098 [No Abstract] [Full Text] [Related]
8. Effect of plasma oncotic pressure on apolipoprotein levels in rats with Heymann nephritis. Kaysen GA; Jones H; Joles JA; van Tol A Miner Electrolyte Metab; 1996; 22(1-3):31-8. PubMed ID: 8676821 [TBL] [Abstract][Full Text] [Related]
9. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children. Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787 [TBL] [Abstract][Full Text] [Related]
10. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome. El-Melegy NT; Mohamed NA; Sayed MM Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747 [TBL] [Abstract][Full Text] [Related]
11. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine. van Hooff JP; Bessems P; Beuman GH; Leunissen KM Transplant Proc; 1988 Apr; 20(2 Suppl 2):640. PubMed ID: 3363660 [No Abstract] [Full Text] [Related]
12. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats. Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584 [TBL] [Abstract][Full Text] [Related]
13. The effect of obesity on cyclosporine pharmacokinetics in uremic patients. Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464 [No Abstract] [Full Text] [Related]
14. Subcutaneous absorption of cyclosporine in rabbits. Shah AK; Sawchuk RJ; Gratwohl A; Baldomero H; Speck B Transplant Proc; 1988 Apr; 20(2 Suppl 2):710-4. PubMed ID: 3363667 [No Abstract] [Full Text] [Related]
15. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria. Adigun MO; Agbedana EO; Kadiri S; Taylor GO Afr J Med Med Sci; 1999; 28(1-2):97-100. PubMed ID: 12953996 [TBL] [Abstract][Full Text] [Related]
16. Ocular bioavailability of cyclosporine after oral administration. Tabbara KF; Gee SS; Alvarez H Transplant Proc; 1988 Apr; 20(2 Suppl 2):656-9. PubMed ID: 3363663 [No Abstract] [Full Text] [Related]
17. Comparison of cyclosporine A and G pharmacokinetics. D'Souza MJ; Gourdikian KB; Mujukian AL Drug Metab Dispos; 1988; 16(6):895-7. PubMed ID: 2907472 [No Abstract] [Full Text] [Related]
18. [About two cases of massive hypercholesterolemia]. Perier C; Raby N; Atieh S; Granouillet R; Chamson A Ann Biol Clin (Paris); 2005; 63(2):217-9. PubMed ID: 15771981 [TBL] [Abstract][Full Text] [Related]
19. [Serum apolipoprotein abnormalities in patients with idiopathic nephrotic syndrome]. Zhang H; Huang WC; Tang SC Zhonghua Yi Xue Za Zhi; 1994 Sep; 74(9):542-4, 582-3. PubMed ID: 7842352 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors. Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]